← Open Payments lookup

ADAORA NNANNA: Open Payments

NPI 1396294161 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$654 in 30 payments from 10 companies in 2025. Trend: 2023 $689 · 2024 $992 · 2025 $654

Food & beverage: $654
CompanyPaymentsAmount
ABBVIE INC.7$166
Neurocrine BioSciences, Inc.5$133
Vanda Pharmaceuticals Inc.4$102
Tris Pharma Inc6$98
Corium, LLC2$45
Supernus Pharmaceuticals, Inc.2$29
Teva Pharmaceuticals USA, Inc.1$25
Axsome Therapeutics, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$20
Collegium Pharmaceutical, Inc.1$16

Products named: VRAYLAR, INGREZZA, Dyanavel XR, HETLIOZ, Azstarys, Qelbree, AUSTEDO XR, FANAPT.

Industry payments across MD — which companies pay providers there.